MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Sánchez-Espiridión, Beatriz, Martín-Moreno, Ana M., Montalbán, Carlos, Figueroa, Vianihuini, Vega, Francisco, Younes, Anas, Medeiros, L. Jeffrey, Alvés, Francisco J., Canales, Miguel, Estévez, Mónica, Menarguez, Javier, Sabín, Pilar, Ruiz-Marcellán, María C., Lopez, Andrés, Sánchez-Godoy, Pedro, Burgos, Fernando, Santonja, Carlos, López, José L., Piris, Miguel A., Garcia, Juan F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291117/
https://ncbi.nlm.nih.gov/pubmed/23725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados